Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0Z6BZ
|
|||
| Former ID |
DNC013788
|
|||
| Drug Name |
Biphenyl-3-ylcarbamic Acid Biphenyl-3-yl Ester
|
|||
| Synonyms |
CHEMBL451443; Biphenyl-3-ylcarbamic Acid Biphenyl-3-yl Ester; URB602, 3j
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C25H19NO2
|
|||
| Canonical SMILES |
C1=CC=C(C=C1)C2=CC(=CC=C2)NC(=O)OC3=CC=CC(=C3)C4=CC=CC=C4
|
|||
| InChI |
1S/C25H19NO2/c27-25(26-23-15-7-13-21(17-23)19-9-3-1-4-10-19)28-24-16-8-14-22(18-24)20-11-5-2-6-12-20/h1-18H,(H,26,27)
|
|||
| InChIKey |
GJGNAZXEUGJLTC-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
| BioCyc | Anandamide degradation | |||
| KEGG Pathway | Retrograde endocannabinoid signaling | |||
| Panther Pathway | Anandamide degradation | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Synthesis and quantitative structure-activity relationship of fatty acid amide hydrolase inhibitors: modulation at the N-portion of biphenyl-3-yl a... J Med Chem. 2008 Jun 26;51(12):3487-98. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.